{"content":"<li class=\"n-box-item date-title\" data-end=\"1511845199\" data-start=\"1511758800\" data-txt=\"Monday, December 23, 2019\">Monday, November 27, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3314622\" data-ts=\"1511824698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASC\" target=\"_blank\">ASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314622-ardmore-shipping-announces-5_58m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardmore Shipping announces 5.58M-share secondary offering</a></h4><ul>     <li>Ardmore Shipping (NYSE:<a href='https://seekingalpha.com/symbol/ASC' title='Ardmore Shipping Corp'>ASC</a>) <font color='red'>-9.6%</font> after-hours on news that it filed for a <a href=\"https://seekingalpha.com/pr/17011135-ardmore-shipping-corporation-announces-secondary-public-offering-ga-holdings-llc-ardmores\" target=\"_blank\">secondary public offering</a> of ~5.58M shares to be sold by GA Holdings, which also intends to grant the underwriters an option to purchase up to an additional ~634K shares.</li>     <li>ASC will purchase from the underwriter 1.35M common shares and purchase from the selling shareholder an additional ~85K shares.</li>     <li>ASC will not receive any proceeds from the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314622\" data-linked=\"Ardmore Shipping announces 5.58M-share secondary offering\" data-tweet=\"$ASC - Ardmore Shipping announces 5.58M-share secondary offering https://seekingalpha.com/news/3314622-ardmore-shipping-announces-5_58m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3314622-ardmore-shipping-announces-5_58m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314621\" data-ts=\"1511824472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314621-ekso-bionicsminus-2_9-exec-clears-50000-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso Bionics -2.9% as exec clears 50,000 shares</a></h4><ul>   <li>Ekso Bionics (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) is <font color='red'>off 2.9%</font> in postmarket trading after an <a href=\"https://seekingalpha.com/filing/3778360\" target=\"_blank\">SEC form shows</a> Russ Angold -- president of EksoWorks -- disposed of 50,000 shares.</li>    <li>The sale happened last Wednesday just before the Thanksgiving holiday. Angold sold the shares for $3.51 each, for gross proceeds of $175,500.</li>    <li>Shares are <font color='red'>down 22.8%</font> in 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314621\" data-linked=\"Ekso Bionics -2.9% as exec clears 50,000 shares\" data-tweet=\"$EKSO - Ekso Bionics -2.9% as exec clears 50,000 shares https://seekingalpha.com/news/3314621-ekso-bionicsminus-2_9-exec-clears-50000-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3314621-ekso-bionicsminus-2_9-exec-clears-50000-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314616\" data-ts=\"1511822170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314616-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a> <font color='green'>+26.5%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+10.4%</font>. <a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a> <font color='green'>+9.4%</font>. <a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/TECD' title='Tech Data Corporation'>TECD</a> <font color='green'>+4.6%</font>.</li>     <li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/ASC' title='Ardmore Shipping Corp'>ASC</a> <font color='red'>-9.1%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='red'>-5.6%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a>&nbsp;<font color='red'>-5.3%.&nbsp;</font><a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='red'>-1.6%</font>. <a href='https://seekingalpha.com/symbol/XIN' title='Xinyuan Real Estate Co., Ltd.'>XIN</a>&nbsp;<font color='red'>-1.3</font><font color='red'>%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314616\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$APEN $THO $SRRA - After Hours Gainers / Losers https://seekingalpha.com/news/3314616-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3314616-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314604\" data-ts=\"1511820548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTIC\" target=\"_blank\">OTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314604-otonomy-drops-support-for-otiprio-to-sharpen-focus-on-pipeline-development-shares-up-3-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Otonomy drops support for Otiprio to sharpen focus on pipeline development; shares up 3% after hours</a></h4><ul><li>Otonomy (NASDAQ:<a href='https://seekingalpha.com/symbol/OTIC' title='Otonomy'>OTIC</a>) is up&nbsp;<font color='green'>3%</font>&nbsp;after hours on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17011218-otonomy-announces-plan-focus-resources-development-programs\" target=\"_blank\">announcement </a>that it has terminated commercial support of OTIPRIO (ciprofloxacin otic suspension) so it can focus its resources on developing its pipeline, especially OTIVIDEX for M&eacute;ni&egrave;re&rsquo;s disease.</li><li>The company the action should save ~$20M next year. Discussions are apparently underway to divest OTIPRIO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314604\" data-linked=\"Otonomy drops support for Otiprio to sharpen focus on pipeline development; shares up 3% after hours\" data-tweet=\"$OTIC - Otonomy drops support for Otiprio to sharpen focus on pipeline development; shares up 3% after hours https://seekingalpha.com/news/3314604-otonomy-drops-support-for-otiprio-to-sharpen-focus-on-pipeline-development-shares-up-3-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3314604-otonomy-drops-support-for-otiprio-to-sharpen-focus-on-pipeline-development-shares-up-3-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314600\" data-ts=\"1511819858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314600-aeterna-zentaris-european-marketing-application-for-macrilen-for-aghd-accepted-for-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeterna Zentaris&#39; European marketing application for Macrilen for AGHD accepted for review; shares up 16% after hours</a></h4><ul><li>The European Medicines Agency <a href=\"https://seekingalpha.com/pr/17011232-aeterna-zentaris-marketing-authorization-application-macrilen-macimorelin-evaluation-adult\" target=\"_blank\">accepts for review</a> Aeterna Zentaris' (NASDAQ:<a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a>) marketing application seeking approval for Macrilen (macimorelin) for the evaluation of adult growth hormone deficiency &#40;AGHD&#41;.</li><li>The official start of the review period was November 23 so the EMA's action date, assuming the standard 210-day review period, is June 21, 2018.</li><li>Shares are up&nbsp;<font color='green'>16%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314600\" data-linked=\"Aeterna Zentaris&#39; European marketing application for Macrilen for AGHD accepted for review; shares up 16% after hours\" data-tweet=\"$AEZS - Aeterna Zentaris&#39; European marketing application for Macrilen for AGHD accepted for review; shares up 16% after hours https://seekingalpha.com/news/3314600-aeterna-zentaris-european-marketing-application-for-macrilen-for-aghd-accepted-for-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3314600-aeterna-zentaris-european-marketing-application-for-macrilen-for-aghd-accepted-for-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314598\" data-ts=\"1511819692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GVP\" target=\"_blank\">GVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314598-gse-systems-announces-sim-platform-implementation-major-client\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSE Systems announces sim platform implementation by major client</a></h4><ul><li>        GSE Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/GVP' title='GSE Systems, Inc'>GVP</a>) <a href=\"https://seekingalpha.com/pr/17011205-gse-systems-latest-simulation-platform-selected-major-client-fleet-solution-nuclear-operator\" target=\"_blank\">announces</a> an unnamed existing client is implementing the OpenSim simulation platform across all of the client&rsquo;s nuclear plant sites in the southern U.S.</li><li>        No financial terms were disclosed.</li><li>               GSE shares are&nbsp;<font color='green'>up 3%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3314598\" data-linked=\"GSE Systems announces sim platform implementation by major client\" data-tweet=\"$GVP - GSE Systems announces sim platform implementation by major client https://seekingalpha.com/news/3314598-gse-systems-announces-sim-platform-implementation-major-client?source=tweet\" data-url=\"https://seekingalpha.com/news/3314598-gse-systems-announces-sim-platform-implementation-major-client\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314597\" data-ts=\"1511819100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314597-zendesk-appoints-workday-exec-to-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zendesk appoints Workday exec to board</a></h4><ul><li>        Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) <a href=\"https://seekingalpha.com/pr/17011185-zendesk-adds-workday-executive-mike-frandsen-board-directors\" target=\"_blank\">appoints</a> Mike Frandsen, Workday&rsquo;s executive director of products, to its board.&nbsp;</li><li>               Frandsen&rsquo;s work history also includes stints at the Intel-acquired DemandTec and Oracle-acquired PeopleSoft.&nbsp;</li><li>               Zendesk shares are&nbsp;<font color='green'>up 2.9%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3306946-zendesk-beats-0_04-beats-revenue\" target=\"_blank\">Zendesk beats by $0.04, beats on revenue</a> (Nov. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314597\" data-linked=\"Zendesk appoints Workday exec to board\" data-tweet=\"$ZEN - Zendesk appoints Workday exec to board https://seekingalpha.com/news/3314597-zendesk-appoints-workday-exec-to-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3314597-zendesk-appoints-workday-exec-to-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314596\" data-ts=\"1511819084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEDP\" target=\"_blank\">MEDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314596-medpace-readies-4m-share-stock-offering-from-current-investor-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medpace readies 4M-share stock offering from current investor; shares down 2% after hours</a></h4><ul><li>Medpace Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MEDP' title='Medpace Holdings'>MEDP</a>) slips<font color='red'> 2%&nbsp;</font>after hours on light volume in response to its planned <a href=\"https://seekingalpha.com/pr/17011192-medpace-holdings-inc-announces-commencement-proposed-secondary-offering-common-stock-selling\" target=\"_blank\">secondary offering</a> of 4M common shares held by affiliates of institutional investor Cinven Capital Management &#40;V&#41; General Partner Limited.</li><li>The company will receive no proceeds from the sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314596\" data-linked=\"Medpace readies 4M-share stock offering from current investor; shares down 2% after hours\" data-tweet=\"$MEDP - Medpace readies 4M-share stock offering from current investor; shares down 2% after hours https://seekingalpha.com/news/3314596-medpace-readies-4m-share-stock-offering-from-current-investor-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3314596-medpace-readies-4m-share-stock-offering-from-current-investor-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314594\" data-ts=\"1511818758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314594-unitedhealth-sees-2018-non-gaap-eps-growth-of-5_5-8_5-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UnitedHealth sees 2018 non-GAAP EPS growth of 5.5 - 8.5%; shares down 1% after hours</a></h4><ul><li>UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a>) <a href=\"https://seekingalpha.com/pr/17011179-unitedhealth-group-discuss-business-outlook-investor-conference\" target=\"_blank\">updates </a>guidance ahead of tomorrow's Investor Conference in New York.</li><li><strong>2017</strong>: Revenues: at least $200B; EPS: ~$9.45; non-GAAP EPS: ~$10.00.</li><li><strong>2018</strong>: Revenues: $223B - 225B; EPS: $10.00 - 10.30; non-GAAP EPS: $10.55 - 10.85; CF Ops: $13.3B - 13.8B.</li><li>2018 consensus: Non-GAAP EPS of $10.83 on revenues of $218B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314594\" data-linked=\"UnitedHealth sees 2018 non-GAAP EPS growth of 5.5 - 8.5%; shares down 1% after hours\" data-tweet=\"$UNH - UnitedHealth sees 2018 non-GAAP EPS growth of 5.5 - 8.5%; shares down 1% after hours https://seekingalpha.com/news/3314594-unitedhealth-sees-2018-non-gaap-eps-growth-of-5_5-8_5-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3314594-unitedhealth-sees-2018-non-gaap-eps-growth-of-5_5-8_5-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314589\" data-ts=\"1511818286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECD\" target=\"_blank\">TECD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314589-tech-data-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech Data beats by $0.08, beats on revenue</a></h4><ul><li>Tech Data (NASDAQ:<a href='https://seekingalpha.com/symbol/TECD' title='Tech Data Corporation'>TECD</a>): Q3 EPS of $2.00 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $9.14B (+40.8% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+2.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17011217-tech-data-corporation-reports-third-quarter-fiscal-year-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3314589\" data-linked=\"Tech Data beats by $0.08, beats on revenue\" data-tweet=\"$TECD - Tech Data beats by $0.08, beats on revenue https://seekingalpha.com/news/3314589-tech-data-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3314589-tech-data-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314583\" data-ts=\"1511817979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314583-aratana-launches-35m-stock-offering-shares-off-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana launches $35M stock offering; shares off 5% after hours</a></h4><ul><li>Thinly traded micro cap Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a>) slips&nbsp;<font color='red'>5%</font>&nbsp;after hours in response to its planned $35M <a href=\"https://seekingalpha.com/pr/17011166-aratana-therapeutics-inc-announces-proposed-public-offering\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314583\" data-linked=\"Aratana launches $35M stock offering; shares off 5% after hours\" data-tweet=\"$PETX - Aratana launches $35M stock offering; shares off 5% after hours https://seekingalpha.com/news/3314583-aratana-launches-35m-stock-offering-shares-off-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3314583-aratana-launches-35m-stock-offering-shares-off-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314581\" data-ts=\"1511817642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTSC\" target=\"_blank\">MTSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314581-mts-systemsminus-5_7-after-q4-beats-mixed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MTS Systems -5.7% after Q4 beats, mixed guidance</a></h4><ul><li>        MTS Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSC' title='MTS Systems Corporation'>MTSC</a>) shares&nbsp;<font color='red'>drop 5.7%</font>&nbsp;aftermarket following Q4 results that beat EPS and revenue estimates.</li><li>               Mixed FY18 guidance has revenue from $780M to $820M (consensus: $810.55M) and EPS from $2.05 to $2.30 (consensus: $2.51).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17011142-mts-reports-fiscal-year-2017-fourth-quarter-full-year-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314572-mts-systems-beats-0_08-beats-revenue\" target=\"_blank\">MTS Systems beats by $0.08, beats on revenue</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314581\" data-linked=\"MTS Systems -5.7% after Q4 beats, mixed guidance\" data-tweet=\"$MTSC - MTS Systems -5.7% after Q4 beats, mixed guidance https://seekingalpha.com/news/3314581-mts-systemsminus-5_7-after-q4-beats-mixed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3314581-mts-systemsminus-5_7-after-q4-beats-mixed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314580\" data-ts=\"1511817523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314580-fda-accepts-dova-pharmas-marketing-application-for-avatrombopag-for-thrombocytopenia-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Dova Pharma&#39;s marketing application for avatrombopag for thrombocytopenia, action date May 21, 2018; shares ahead 1% after hours</a></h4><ul><li>Thinly traded Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a>) perks up&nbsp;<font color='green'>1%</font>&nbsp;after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17011151-dova-pharmaceuticals-announces-fda-acceptance-avatrombopag-new-drug-application-nda-priority\" target=\"_blank\">announcement </a>that the FDA has accepted for review its marketing application seeking approval for avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease about to undergo a procedure.</li><li>Under Priority Review status, the agency's action date is May 21, 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314580\" data-linked=\"FDA accepts Dova Pharma&#39;s marketing application for avatrombopag for thrombocytopenia, action date May 21, 2018; shares ahead 1% after hours\" data-tweet=\"$DOVA - FDA accepts Dova Pharma&#39;s marketing application for avatrombopag for thrombocytopenia, action date May 21, 2018; shares ahead 1% after hours https://seekingalpha.com/news/3314580-fda-accepts-dova-pharmas-marketing-application-for-avatrombopag-for-thrombocytopenia-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3314580-fda-accepts-dova-pharmas-marketing-application-for-avatrombopag-for-thrombocytopenia-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314578\" data-ts=\"1511817412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314578-thor-beats-0_59-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor beats by $0.59, beats on revenue</a></h4><ul><li>Thor (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>): Q1 EPS of $2.43 <font color='green'>beats by $0.59</font>.</li><li>Revenue of $2.23B (+30.4% Y/Y) <font color='green'>beats by $240M</font>.</li><li>Shares <font color='green'>+4.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17011171-thor-announces-record-results-first-quarter-fiscal-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3314578\" data-linked=\"Thor beats by $0.59, beats on revenue\" data-tweet=\"$THO - Thor beats by $0.59, beats on revenue https://seekingalpha.com/news/3314578-thor-beats-0_59-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3314578-thor-beats-0_59-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314575\" data-ts=\"1511817239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314575-catalyst-pharma-launches-11m-share-stock-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma launches 11M-share stock offering; shares down 4% after hours</a></h4><ul><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) readies a <a href=\"https://seekingalpha.com/pr/17011133-catalyst-pharmaceuticals-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of 11M common shares. Price and terms have yet to be released.</li><li>Shares are off&nbsp;<font color='red'>4%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314575\" data-linked=\"Catalyst Pharma launches 11M-share stock offering; shares down 4% after hours\" data-tweet=\"$CPRX - Catalyst Pharma launches 11M-share stock offering; shares down 4% after hours https://seekingalpha.com/news/3314575-catalyst-pharma-launches-11m-share-stock-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3314575-catalyst-pharma-launches-11m-share-stock-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314571\" data-ts=\"1511817046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314571-cowen-raises-marvell-tech-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen raises its Marvell Tech price target</a></h4><ul><li>        Cowen <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171127055437CALLS\" target=\"_blank\">raises</a> its Marvell Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) price target from $21 to $29.</li><li>               Firm says color around Cavium deal is all that matters going into the October quarter earnings.&nbsp;</li><li>               Cowen thinks the Street is undervaluing the company&rsquo;s potential for CY18.&nbsp;</li><li>               Firm sees organic EPS of $1.60 and CY19 EPS near $2.&nbsp;</li><li>               Marvell shares closed today&nbsp;<font color='red'>down 1.76%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313986-bloomberg-starboard-vote-marvell-cavium-deal\" target=\"_blank\">Bloomberg: Starboard to vote for Marvell-Cavium deal</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314571\" data-linked=\"Cowen raises its Marvell Tech price target\" data-tweet=\"$MRVL - Cowen raises its Marvell Tech price target https://seekingalpha.com/news/3314571-cowen-raises-marvell-tech-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3314571-cowen-raises-marvell-tech-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314563\" data-ts=\"1511816430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMSWA\" target=\"_blank\">AMSWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314563-american-software-subsidiary-acquires-analytics-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Software subsidiary acquires analytics company</a></h4><ul><li>        American Software (NASDAQ:<a href='https://seekingalpha.com/symbol/AMSWA' title='American Software, Inc.'>AMSWA</a>) subsidiary Logility <a href=\"http://www.businesswire.com/news/home/20171127005243/en/Logility-Acquires-Halo-Business-Intelligence-Expand-Advanced\" target=\"_blank\">acquires</a> Halo Business Intelligence, a supplier of advanced analytics and business intelligence solutions for the supply chain.</li><li>               The acquisition expands Logility&rsquo;s advanced analytics through AI and machine learning.&nbsp;</li><li>               No financial terms disclosed. &nbsp;&nbsp;</li><li>                  American Software shares are&nbsp;<font color='green'>up 1.7%</font>. </li></ul><div class=\"tiny-share-widget\" data-id=\"3314563\" data-linked=\"American Software subsidiary acquires analytics company\" data-tweet=\"$AMSWA - American Software subsidiary acquires analytics company https://seekingalpha.com/news/3314563-american-software-subsidiary-acquires-analytics-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3314563-american-software-subsidiary-acquires-analytics-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314560\" data-ts=\"1511814933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314560-moffett-sprint-t-mobile-breakup-good-for-sector-except-sprint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moffett: Sprint/T-Mobile breakup good for sector (except Sprint)</a></h4><ul>   <li>T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+0.8%</font>) earned an upgrade to Buy from MoffettNathanson, which says the <a href=\"https://www.barrons.com/articles/t-mobile-to-benefit-from-collapse-of-sprint-deal-says-moffett-nathanson-1511793391\" target=\"_blank\">breakup of merger talks</a> with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+0.2%</font>) will ultimately benefit the upstart No. 3 carrier.</li>    <li>The collapse of the deal \"will ultimately prove to be good news for the sector,\" writes Craig Moffett, though with one clear loser: &ldquo;Robbed of the prospect of a merger &mdash; at least for now &mdash; Sprint will now have to focus on sustainability. That means less, not more, promotionality.\"</li>    <li>And that means fewer net subscriber additions, which will be absorbed by Sprint's rivals, he adds.</li>    <li>Moffett has raised his price target on <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> to $73 from $69, while trimming his price target on Sprint to $2 from $6. (Sprint's currently at $6.16.)</li>    <li>He's reiterated a Buy on Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='green'>+1.6%</font>; $51 price target) and a Neutral on AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-0.2%</font>), based on wireline troubles, debt and declining revenues at DirecTV.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314560\" data-linked=\"Moffett: Sprint/T-Mobile breakup good for sector (except Sprint)\" data-tweet=\"$TMUS $TMUS $VZ - Moffett: Sprint/T-Mobile breakup good for sector (except Sprint) https://seekingalpha.com/news/3314560-moffett-sprint-t-mobile-breakup-good-for-sector-except-sprint?source=tweet\" data-url=\"https://seekingalpha.com/news/3314560-moffett-sprint-t-mobile-breakup-good-for-sector-except-sprint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314559\" data-ts=\"1511814639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314559-bofaml-raises-vmware-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML raises its VMware price target</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiwu_2ey9_XAhXM8YMKHZHSAAoQqQIIKigAMAE&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FVMware%2B%28VMW%29%3A%2BRaising%2BPT%2BAhead%2Bof%2BAWS%2BConference%2B-%2BBofA%2F13540169.html&amp;usg=AOvVaw215XNOxD6BKV23muq7G6c-\" target=\"_blank\">raises</a> its VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) price target from $125 to $148.</li><li>               The raise came ahead of the Amazon Web Services re:Invent conference, which kicked off today and runs through Friday. &nbsp;</li><li>                  VMware shares are&nbsp;<font color='green'>up 1.6%</font>. &nbsp; &nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3309228-information-vmware-circling-security-acquisitions\" target=\"_blank\">The Information: VMware circling security acquisitions</a> (Nov. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314559\" data-linked=\"BofAML raises its VMware price target\" data-tweet=\"$VMW - BofAML raises its VMware price target https://seekingalpha.com/news/3314559-bofaml-raises-vmware-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3314559-bofaml-raises-vmware-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314555\" data-ts=\"1511813603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUDA\" target=\"_blank\">CUDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314555-barracuda-downgraded-analysts-see-topping-bids-unlikely\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barracuda downgraded as analysts see topping bids unlikely</a></h4><ul>   <li>Shares in Barracuda Networks (<a href=\"http://seekingalpha.com/symbol/CUDA\" target=\"_blank\">CUDA</a> <font color='green'>+16.5%</font>), up large today on word of a <a href=\"https://seekingalpha.com/news/3314452-barracuda-networks-plus-15_7-percent-1_6b-go-private-deal\" target=\"_blank\">go-private bid from Thoma Bravo</a>, have settled in at close to the offer price as analysts downgrade, discounting the prospect of a competing bid.</li>    <li>Piper Jaffray, Stifel Nicolaus, Rosenblatt and BTIG have dropped ratings from Buy to Neutral, with the prospect of a topping offer (as Piper Jaffray says) unlikely.</li>    <li>Meanwhile, KeyBanc thinks the M&amp;A activity on a deeply discounted firm is a positive for similarly discounted peers Fortinet (<a href=\"http://seekingalpha.com/symbol/FTNT\" target=\"_blank\">FTNT</a> <font color='red'>-0.2%</font>) and Rapid7 (<a href=\"http://seekingalpha.com/symbol/RPD\" target=\"_blank\">RPD</a> <font color='green'>+0.5%</font>), though those shares aren't making similar moves today. Consolidation in the sector is likely to continue manifesting via go-private deals, the firm says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314555\" data-linked=\"Barracuda downgraded as analysts see topping bids unlikely\" data-tweet=\"$CUDA $CUDA $FTNT - Barracuda downgraded as analysts see topping bids unlikely https://seekingalpha.com/news/3314555-barracuda-downgraded-analysts-see-topping-bids-unlikely?source=tweet\" data-url=\"https://seekingalpha.com/news/3314555-barracuda-downgraded-analysts-see-topping-bids-unlikely\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314552\" data-ts=\"1511813303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314552-marcato-capital-responds-to-deckers-board-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marcato Capital responds to Deckers board plan</a></h4><ul>         <li>Marcato Capital is barking at Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='red'>-1.7%</font>) again as it asks shareholders to vote for its own nominees to the board.</li>     <li>\"Deckers' announced intention to add new directors is a desperate attempt to avoid accountability for failing to achieve its strategic goals over a period of multiple years,\" reads a missive from the hedge fund.</li>     <li>\"Deckers' stockholders deserve the right to select directors for themselves, and should not leave this important decision to a Board that has failed them time and time again,\" adds Marcato.</li>     <li>Marcato holds about an 8.4% stake in Deckers through funds it manages.</li><li>Shares of Deckers are up 14% over the last 52 weeks to trail the 18% return on the S&amp;P 500 Index.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17011057-marcato-responds-deckers-desperate-attempt-avoid-accountability\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3314552\" data-linked=\"Marcato Capital responds to Deckers board plan\" data-tweet=\"$DECK - Marcato Capital responds to Deckers board plan https://seekingalpha.com/news/3314552-marcato-capital-responds-to-deckers-board-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3314552-marcato-capital-responds-to-deckers-board-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314551\" data-ts=\"1511813023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314551-stratasys-announces-agreement-philips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stratasys announces agreement with Philips</a></h4><ul><li>        Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a>) <a href=\"https://seekingalpha.com/pr/17010914-stratasys-inks-deal-bring-advanced-3d-printed-medical-modeling-global-health-tech-leader\" target=\"_blank\">signs an agreement</a> with Philips for 3D printing in medical modeling.</li><li>               The agreement combines Stratasys&rsquo; Direct Manufacturing parts-on-demand service with Philips&rsquo; IntelliSpace Portal 10 for streamlined interfacing and dedicated workflows.&nbsp;</li><li>               No financial terms disclosed.&nbsp;</li><li>               Stratasys shares are&nbsp;<font color='green'>up 0.84%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3314551\" data-linked=\"Stratasys announces agreement with Philips\" data-tweet=\"$SSYS - Stratasys announces agreement with Philips https://seekingalpha.com/news/3314551-stratasys-announces-agreement-philips?source=tweet\" data-url=\"https://seekingalpha.com/news/3314551-stratasys-announces-agreement-philips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314549\" data-ts=\"1511812531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314549-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><strong>Gainers</strong>:<strong>&nbsp;</strong><a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CUDA' title='Barracuda Networks, Inc'>CUDA</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BV-OLD' title='Bazaarvoice'>BV-OLD</a> <font color='green'>+14%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='red'>-11%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3314549\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$TCCO $UTSI $CUDA - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3314549-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3314549-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314548\" data-ts=\"1511812216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314548-solaredgeminus-3-deutsche-bank-downgrades-to-hold-from-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarEdge -3% as Deutsche Bank downgrades to Hold from Buy</a></h4><ul>     <li>SolarEdge Technologies (<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='red'>-2.9%</font>) sinks after Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Downgrades+SolarEdge+Technologies+%28SEDG%29+to+Hold/13540086.html\" target=\"_blank\">downgrades</a> shares to Hold from Buy, believing shares are fully discounting prospects of strong execution in solar and non-solar segments.</li><li>The firm also thinks 2018 industry volumes could disappoint to the downside and noise around increased competition from Huawei likely will increase over the next few quarters.</li><li>Deutsche Bank sees no further positive margin tailwind from  stronger international sales, and it expects pricing pressure to intensify as component shortages ease and as Huawei and Enphase become more aggressive on the pricing front.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314548\" data-linked=\"SolarEdge -3% as Deutsche Bank downgrades to Hold from Buy\" data-tweet=\"$SEDG - SolarEdge -3% as Deutsche Bank downgrades to Hold from Buy https://seekingalpha.com/news/3314548-solaredgeminus-3-deutsche-bank-downgrades-to-hold-from-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3314548-solaredgeminus-3-deutsche-bank-downgrades-to-hold-from-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314547\" data-ts=\"1511811568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHIC\" target=\"_blank\">EHIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314547-ehi-car-services-announces-receipt-of-preliminary-non-binding-proposal-to-acquire-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">eHi Car Services announces receipt of preliminary non-binding proposal to acquire the Company</a></h4><ul>     <li>eHi Car Services (<a href='https://seekingalpha.com/symbol/EHIC' title='eHi Car Services'>EHIC</a> <font color='green'>+3%</font>) announced that its Board has received a preliminary non-binding proposal letter dated Nov. 26, 2017, from Goliath Advisors, third party China-based investment fund.</li>     <li>Goliath has proposed to acquire all outstanding common shares of the Company for $13.35 in cash per American depositary share of the Company (each representing two Class A common shares) or US$6.675 in cash per common share of the Company.</li>     <li>The Board &lrm;plans to evaluate the Proposal Letter. The Board cautions the Company's shareholders and others considering trading in its securities that the Board just received the Proposal Letter and no decisions have been made with respect to the Company's response to the Proposal Letter and the transaction contemplated thereby.</li>     <li>The Company does not undertake any obligation to provide any updates with respect to this or any other transaction, except as required under applicable law.</li><li><a href=\"https://seekingalpha.com/pr/17010522-ehi-car-services-announces-receipt-preliminary-non-binding-proposal-acquire-company\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3314547\" data-linked=\"eHi Car Services announces receipt of preliminary non-binding proposal to acquire the Company\" data-tweet=\"$EHIC - eHi Car Services announces receipt of preliminary non-binding proposal to acquire the Company https://seekingalpha.com/news/3314547-ehi-car-services-announces-receipt-of-preliminary-non-binding-proposal-to-acquire-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3314547-ehi-car-services-announces-receipt-of-preliminary-non-binding-proposal-to-acquire-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314544\" data-ts=\"1511810920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314544-stifel-defends-micron-and-nand-after-morgan-stanley-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel defends Micron and NAND after Morgan Stanley comments</a></h4><ul><li>        Stifel <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171127131306MU\" target=\"_blank\">defends</a> Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) after this morning&rsquo;s Morgan Stanley comments.</li><li>               Morgan Stanley increased Micron&rsquo;s price target from $39 to $55 and maintained its Overweight rating.&nbsp;</li><li>               The analyst said he <a href=\"https://www.cnbc.com/2017/11/27/chips-fall-as-morgan-stanley-says-now-is-the-time-to-take-profits.html\" target=\"_blank\">recommended</a> Micron more than other chip stocks, as he&rsquo;s more bullish on DRAM.&nbsp;</li><li>                  Morgan Stanley was less optimistic about NAND pricing.    </li><li>               Stifel counters with a forecast that NAND pricing will fall in-line or better than the firm&rsquo;s estimates. &nbsp;&nbsp;</li><li>Micron shares are&nbsp;<font color='red'>down 3.4%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3314370-morgan-stanley-cuts-view-samsung-electronics\" target=\"_blank\">Morgan Stanley cuts view on Samsung Electronics</a> (Nov. 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314420-morgan-stanley-downgrades-tsmc-chipmakers-fall\" target=\"_blank\">Morgan Stanley downgrades TSMC, chipmakers fall</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314544\" data-linked=\"Stifel defends Micron and NAND after Morgan Stanley comments\" data-tweet=\"$MU - Stifel defends Micron and NAND after Morgan Stanley comments https://seekingalpha.com/news/3314544-stifel-defends-micron-and-nand-after-morgan-stanley-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/3314544-stifel-defends-micron-and-nand-after-morgan-stanley-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314543\" data-ts=\"1511810608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENB\" target=\"_blank\">ENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314543-enbridge-wins-deal-michigan-on-line-5-pipeline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enbridge wins deal with Michigan on Line 5 pipeline</a></h4><ul><li>Enbridge (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-2.3%</font>) says it has <a href=\"http://business.financialpost.com/commodities/energy/enbridge-reaches-deal-with-michigan-on-underwater-great-lakes-pipeline\" target=\"_blank\">reached a deal with Michigan authorities</a> on the aging Line 5  pipelines that run along the bottom of the Straits of Mackinac between Lake Huron  and Lake Michigan.</li><li>ENB says the agreement includes  completing an evaluation by next June on three potential options to eventually  replace the 7-km stretch of underwater pipeline and immediate safety measures to reduce the risk of a leak.</li><li>The twin pipelines were laid in 1953 and have raised concerns  about the potential impact on the Great Lakes if the  540K bbl/day pipeline were to leak; Line 5 operates currently at less than 25% of maximum pressure capacity for enhanced safety.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314543\" data-linked=\"Enbridge wins deal with Michigan on Line 5 pipeline\" data-tweet=\"$ENB - Enbridge wins deal with Michigan on Line 5 pipeline https://seekingalpha.com/news/3314543-enbridge-wins-deal-michigan-on-line-5-pipeline?source=tweet\" data-url=\"https://seekingalpha.com/news/3314543-enbridge-wins-deal-michigan-on-line-5-pipeline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314542\" data-ts=\"1511809708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZN\" target=\"_blank\">ZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314542-zion-oilplus-13-after-winning-extension-on-megiddo-jezreel-license\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zion Oil +13% after winning extension on Megiddo-Jezreel license</a></h4><ul>     <li>Zion Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+13.1%</font>) shoots higher after receiving a <a href=\"https://seekingalpha.com/pr/17010990-zion-oil-and-gas-receives-multi-year-extension-megiddo-jezreel-license\" target=\"_blank\">two-year extension</a> from Israeli regulators on its Megiddo-Jezreel License No. 401, extending its validity to December 2019.</li>     <li>\"This multi-year extension should assure investors that our current well will continue unabated, without the risk that the Energy Ministry would pull our license,\" ZN says.</li>     <li>ZN President Dustin Guinn says the company is preparing to resume drilling operations.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314542\" data-linked=\"Zion Oil +13% after winning extension on Megiddo-Jezreel license\" data-tweet=\"$ZN - Zion Oil +13% after winning extension on Megiddo-Jezreel license https://seekingalpha.com/news/3314542-zion-oilplus-13-after-winning-extension-on-megiddo-jezreel-license?source=tweet\" data-url=\"https://seekingalpha.com/news/3314542-zion-oilplus-13-after-winning-extension-on-megiddo-jezreel-license\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314541\" data-ts=\"1511809240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314541-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/METC' title='Ramaco'>METC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PZG' title='Paramount Gold Nevada Corp.'>PZG</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='green'>+%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/EPE' title='EP Energy Corporation'>EPE</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314541\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$NOG $ZN $METC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3314541-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3314541-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314539\" data-ts=\"1511809002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCI\" target=\"_blank\">JCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314539-insider-buying-johnson-controls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buying at Johnson Controls</a></h4><ul>     <li>Johnson Control International (<a href='https://seekingalpha.com/symbol/JCI' title='Johnson Controls International plc'>JCI</a> <font color='green'>+0.3%</font>) is back in positive territory for the day after the company reports that CEO George Oliver picked up shares.</li><li>Oliver disclosed buying 27.3K shares at an average of $36.80. The exec now holds just under 635K shares.</li><li><a href=\"https://seekingalpha.com/filing/3777982\" target=\"_blank\">SEC Form 4</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3314539\" data-linked=\"Insider buying at Johnson Controls\" data-tweet=\"$JCI - Insider buying at Johnson Controls https://seekingalpha.com/news/3314539-insider-buying-johnson-controls?source=tweet\" data-url=\"https://seekingalpha.com/news/3314539-insider-buying-johnson-controls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314538\" data-ts=\"1511808013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JMEI\" target=\"_blank\">JMEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314538-buyers-group-pulls-jumei-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buyers group pulls Jumei offer</a></h4><ul>     <li>Jumei International Holding (<a href='https://seekingalpha.com/symbol/JMEI' title='Jumei International Holding Limited'>JMEI</a> <font color='green'>+11.6%</font>)&nbsp;announced that a special board committee received a letter from a buyers group led by Sequoia Capital on the withdrawal of its non-binding going private proposal at $7 per ADS.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17010776-jumei-announces-receipt-withdrawal-buyer-groups-going-private-proposal\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3314538\" data-linked=\"Buyers group pulls Jumei offer\" data-tweet=\"$JMEI - Buyers group pulls Jumei offer https://seekingalpha.com/news/3314538-buyers-group-pulls-jumei-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3314538-buyers-group-pulls-jumei-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314537\" data-ts=\"1511807877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314537-mexico-lower-morgan-stanley-goes-underweight-finmin-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexico lower as Morgan Stanley goes underweight; finmin resigns</a></h4><ul><li>Ahead of what's expected to be a run at the presidency, Mexican Finance Minister Jos&eacute; Antonio Meade <a href=\"https://www.wsj.com/articles/mexican-finance-minister-jose-antonio-meade-resigns-1511805397\" target=\"_blank\">has resigned his position</a>. He's seen as possibly being named the presidential candidate of the ruling Institutional Revolutionary Party in February.</li><li>Citing political uncertainly ahead of the 2018 elections (though not having to do with Meade's resignation, which was expected), Morgan Stanley trims its outlook on Mexican shares to Underweight from Neutral.</li><li>The iShares MSCI Mexico Index (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>) is off its worst levels, but&nbsp;<font color='red'>down 0.5%&nbsp;</font>on the session.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>, <a href='https://seekingalpha.com/symbol/MXF' title='Mexico Fund'>MXF</a>, <a href='https://seekingalpha.com/symbol/MXE' title='Mexico Equity&Income Fund'>MXE</a>, <a href='https://seekingalpha.com/symbol/DBMX' title='Deutsche X-trackers MSCI Mexico Hedged Equity ETF'>DBMX</a>, <a href='https://seekingalpha.com/symbol/HEWW' title='iShares Currency Hedged MSCI Mexico ETF'>HEWW</a>, <a href='https://seekingalpha.com/symbol/MEXX' title='Direxion Daily MSCI Mexico Bull 3X ETF'>MEXX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3314537\" data-linked=\"Mexico lower as Morgan Stanley goes underweight; finmin resigns\" data-tweet=\"$EWW $MXF $MXE - Mexico lower as Morgan Stanley goes underweight; finmin resigns https://seekingalpha.com/news/3314537-mexico-lower-morgan-stanley-goes-underweight-finmin-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3314537-mexico-lower-morgan-stanley-goes-underweight-finmin-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314522\" data-ts=\"1511805642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314522-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='green'>+18%</font>.<a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/XIN' title='Xinyuan Real Estate Co., Ltd.'>XIN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FAC' title='First Acceptance Corporation'>FAC</a> <font color='green'>+%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314522\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GROW $OPHC $QD - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3314522-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3314522-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314524\" data-ts=\"1511804938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRZO\" target=\"_blank\">CRZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314524-carrizo-oil-gas-sells-dj-basin-assets-for-140m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carrizo Oil &amp; Gas sells DJ Basin assets for $140M</a></h4><ul>     <li>Carrizo Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='red'>-7.2%</font>) <a href=\"https://seekingalpha.com/pr/17010376-carrizo-oil-and-gas-provides-update-divestiture-program\" target=\"_blank\">agrees to sell</a> its assets in the DJ Basin to an unnamed buyer for $140M plus up to $15M contingent payments based on crude oil prices exceeding certain thresholds over the next three years.</li>     <li>CRZO says net production from the assets totaled 2,427 boe/day (69% oil, 84% liquids) during Q3.</li>     <li>CRZO also says it closed on a pair of previously announced divestitures in the Appalachia region, selling all of its in the Utica and Marcellus shale formations for a combined $146M.</li>     <li>Stifel analysts <a href=\"https://www.streetinsider.com/Analyst+Comments/Carrizo+Oil+%26+Gas+%28CRZO%29+PT+Raised+to+%2442+at+Stifel+Following+Announced+DJ+Basin+Divestment/13540973.html\" target=\"_blank\">raise their stock price target</a> for CRZO to $42 following the sale, but shares are sharply lower as U.S. crude oil falls ~1.4% to $58.13/bbl.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314524\" data-linked=\"Carrizo Oil &amp; Gas sells DJ Basin assets for $140M\" data-tweet=\"$CRZO - Carrizo Oil &amp; Gas sells DJ Basin assets for $140M https://seekingalpha.com/news/3314524-carrizo-oil-gas-sells-dj-basin-assets-for-140m?source=tweet\" data-url=\"https://seekingalpha.com/news/3314524-carrizo-oil-gas-sells-dj-basin-assets-for-140m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314521\" data-ts=\"1511804589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314521-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/MGCD' title='MGC Diagnostics Corporation'>MGCD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/SGRP' title='SPAR Group, Inc.'>SGRP</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CUDA' title='Barracuda Networks, Inc'>CUDA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='green'>+16%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MICT' title='Micronet Enertec Technologies, Inc.'>MICT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/QDEL' title='Quidel Corporation'>QDEL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='red'>-12%</font>.</li>      &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3314521\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CERC $MARA $MGCD - Midday Gainers / Losers https://seekingalpha.com/news/3314521-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3314521-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314517\" data-ts=\"1511803499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314517-ocular-continues-crl-stoked-slide-down-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular continues CRL-stoked slide, down 17%</a></h4><ul><li>Thinly traded micro cap Ocular Therapeutix (<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-16.6%</font>) is down on a 5x surge in volume. Shares have lost almost 70% of their value since the company received a second CRL from the FDA related to its marketing application for Dextenza.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278064-ocular-therapeutix-minus-30-percent-fda-denies-nda-dextenza\" target=\"_blank\">Ocular Therapeutix -30% as FDA denies NDA for Dextenza</a> (July 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3195439-fda-rejects-oculars-dextenza-nda-ocular-pain-shares-4-percent-premarket\" target=\"_blank\">FDA rejects Ocular's Dextenza NDA for ocular pain; shares off 4% premarket</a> (July 25, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314517\" data-linked=\"Ocular continues CRL-stoked slide, down 17%\" data-tweet=\"$OCUL - Ocular continues CRL-stoked slide, down 17% https://seekingalpha.com/news/3314517-ocular-continues-crl-stoked-slide-down-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3314517-ocular-continues-crl-stoked-slide-down-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314515\" data-ts=\"1511803210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314515-join-crypto-club\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More join the crypto club</a></h4><ul><li>Forget politics. It sounds like Bitcoin was the big topic of discussion at Thanksgiving family gatherings. Judging by the action in the price of cryptos and in new accounts at exchanges like Coinbase, returning college students and millennials convinced grandparents, parents, aunts and uncles to jump in with both feet.</li><li>It was <a href=\"https://seekingalpha.com/news/3314371-bitcoin-shoots-10000\" target=\"_blank\">earlier reported that </a>Coinbase added 100K accounts between Wednesday and Friday; that's gone up to 300K (to 13.3M total) as of yesterday.</li><li>As for the price, Bitcoin has pared some of its massive gains since challenging $10K on Sunday, now trading hands at $9,557. Ether and Litecoin also posted huge advances over the weekend.</li><li>Meanwhile, hedge fund giant Ken Griffin <a href=\"https://www.cnbc.com/2017/11/27/citadels-griffin-says-bitcoin-has-elements-of-the-tulip-bulb-mania.html?__source=twitter%7Cmain\" target=\"_blank\">adds his name</a> to the list of those comparing Bitcoin and tulip bulbs.</li><li>Checking related stocks, while Bitcoin Investment Trust (<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color='green'>+17.5%</font>) is surging alongside its underlying asset, names like Riot Blockchain (<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-31%</font>) and Xuniei (<a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-7.5%</font>) are giving back some of their recent massive gains.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3314515\" data-linked=\"More join the crypto club\" data-tweet=\"$GBTC $GBTC $RIOT - More join the crypto club https://seekingalpha.com/news/3314515-join-crypto-club?source=tweet\" data-url=\"https://seekingalpha.com/news/3314515-join-crypto-club\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314510\" data-ts=\"1511802241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWIR\" target=\"_blank\">SWIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314510-sierra-wirelessplus-9_4-raymond-james-moves-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Wireless +9.4% as Raymond James moves to Outperform</a></h4><ul>    <li>Sierra Wireless (NASDAQ:<a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a>) has <font color='green'>gained 9.4%</font> today after Raymond James gave it an upgrade to Outperform, from Market Perform.</li>    <li>That's a move away from the bulk of analysts, more than a half-dozen of which have Hold-equivalent ratings.</li>    <li>Shares are <font color='green'>up 32.2%</font> in 2017, but are still about 29% below a 52-week high hit this past summer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314510\" data-linked=\"Sierra Wireless +9.4% as Raymond James moves to Outperform\" data-tweet=\"$SWIR - Sierra Wireless +9.4% as Raymond James moves to Outperform https://seekingalpha.com/news/3314510-sierra-wirelessplus-9_4-raymond-james-moves-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3314510-sierra-wirelessplus-9_4-raymond-james-moves-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314509\" data-ts=\"1511802086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314509-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WILC' title='G. Willi-Food International, Ltd.'>WILC</a> <font color='green'>+7%</font>. ONP <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='red'>-7%</font>. LTEA <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314509\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $WILC $ITP - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3314509-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3314509-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314508\" data-ts=\"1511802055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314508-sharp-drop-for-dave-busters-after-canaccord-lowers-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sharp drop for Dave &amp; Buster&#39;s after Canaccord lowers estimates</a></h4><ul> <li>Dave &amp; Buster's (<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a> <font color='red'>-5.4%</font>)&nbsp;falls sharply after Canaccord Genuity lowers estimates on the retail chain.</li> <li>The firm now expects D&amp;B to report Q3 comparabale sales growth of -3% vs. -1% prior forecast. The hurricanes that hit the U.S. during the quarter are seen as a bigger impact than lower NFL ratings.</li> <li>The Canaccord estimate for restaurant operating margin is dropped 110 bps to 24.1% of sales due to the sales weakness and higher labor costs.</li> <li>Dave &amp; Buster's is due to report earnings after the market closes on December 5.</li><li>Sources: CNBC and Nasdaq.com</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314508\" data-linked=\"Sharp drop for Dave &amp; Buster&#39;s after Canaccord lowers estimates\" data-tweet=\"$PLAY - Sharp drop for Dave &amp; Buster&#39;s after Canaccord lowers estimates https://seekingalpha.com/news/3314508-sharp-drop-for-dave-busters-after-canaccord-lowers-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3314508-sharp-drop-for-dave-busters-after-canaccord-lowers-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314506\" data-ts=\"1511801967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314506-meredith-time-jump-after-deal-time-chief-battista-to-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meredith, Time jump after deal; Time chief Battista to exit</a></h4><ul>   <li>Meredith (NYSE:<a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a>) is <font color='green'>up 8.2%</font> and Time (TIME) <font color='green'>up 9.2%</font> after the two <a href=\"https://seekingalpha.com/news/3314363-meredith-seals-1_85b-deal-time-inc-updated\" target=\"_blank\">came to a a deal to sell the iconic Time</a> to its publishing rival, with more details emerging this morning.</li>    <li>Meredith says the billionaire Koch brothers -- who helped enable the $1.85B bid with $650M in financing from Koch Equity Development -- \"<a href=\"http://beta.latimes.com/business/la-fi-meredith-time-inc-20171126-story.html\" target=\"_blank\">will have no influence</a> on Meredith's editorial or managerial operations\" and won't have a seat on Meredith's board.</li><li>When the Kochs were first connected to a possible deal, speculation mounted over whether the two would try to promote conservative politics through the brands.</li>    <li>Time CEO/President Rich Battista, brought in just over a year ago, will exit after helping with the transition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314506\" data-linked=\"Meredith, Time jump after deal; Time chief Battista to exit\" data-tweet=\"$MDP - Meredith, Time jump after deal; Time chief Battista to exit https://seekingalpha.com/news/3314506-meredith-time-jump-after-deal-time-chief-battista-to-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3314506-meredith-time-jump-after-deal-time-chief-battista-to-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314504\" data-ts=\"1511801417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKYI\" target=\"_blank\">BKYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314504-bio-key-announces-government-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BIO-key announces government project</a></h4><ul><li>        BIO-key International (NASDAQ:<a href='https://seekingalpha.com/symbol/BKYI' title='BIO-key International, Inc.'>BKYI</a>) <a href=\"https://seekingalpha.com/pr/17010575-bio-key-selected-provide-biometric-solution-government-agency\" target=\"_blank\">announces</a> a project with the Province of British Columbia to use the company&rsquo;s fingerprint authentication solution.</li><li>               The province will use the WEB-key solution for positive biometric ID.&nbsp;</li><li>                  Financial terms not disclosed. &nbsp;   </li><li>               BIO-key shares are<font color='green'> up 4.6%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3314504\" data-linked=\"BIO-key announces government project\" data-tweet=\"$BKYI - BIO-key announces government project https://seekingalpha.com/news/3314504-bio-key-announces-government-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3314504-bio-key-announces-government-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314503\" data-ts=\"1511800865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314503-cienaplus-1_6-bofaml-boosts-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena +1.6% as BofAML boosts to Buy</a></h4><ul>   <li>Ciena (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) is <font color='green'>up 1.6%</font> on one of its best days in months, with BofA Merrill Lynch upgrading to Buy from Neutral.</li>    <li>Valuation looks attractive, the firm says, and the company is set to rebound from what it thinks is a temporary issue with spending timing. Ciena's made gains in new verticals that put it into good position, with the current demand softness already reflected in the share price.</li>    <li>The firm has a price target of $28, implying 31.5% upside from today's higher price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314503\" data-linked=\"Ciena +1.6% as BofAML boosts to Buy\" data-tweet=\"$CIEN - Ciena +1.6% as BofAML boosts to Buy https://seekingalpha.com/news/3314503-cienaplus-1_6-bofaml-boosts-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3314503-cienaplus-1_6-bofaml-boosts-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314494\" data-ts=\"1511799946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314494-neptune-up-10-on-plan-for-omegaminus-3-containing-cannabis-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune up 10% on plan for omega-3-containing cannabis products</a></h4><ul><li>Thinly traded micro cap Neptune Technologies &amp; Bioressources (<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+9.6%</font>) is up on almost a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17010572-neptune-extends-global-maxsimil-licence-cannabis-derived-products\" target=\"_blank\">announcement </a>that it has inked an exclusive global license agreement to use the MaxSimil technology in cannabis-derived products.</li><li>The contract allows it to research, manufacture and sell cannabis and/or cannabinoid-rich hemp-derived products that contain monoglyceride omega-3-rich ingredients.</li><li><a href=\"http://neptunecorp.com/en/what-we-do/ingredients/maxsimil/\" target=\"_blank\">MaxSimil </a>is an omega-3 fatty acid delivery technology.</li><li>The company has submitted a request to Health Canada to produce cannabis oil under the Access to Cannabis for Medical Purposes Regulations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314494\" data-linked=\"Neptune up 10% on plan for omega-3-containing cannabis products\" data-tweet=\"$NEPT - Neptune up 10% on plan for omega-3-containing cannabis products https://seekingalpha.com/news/3314494-neptune-up-10-on-plan-for-omegaminus-3-containing-cannabis-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3314494-neptune-up-10-on-plan-for-omegaminus-3-containing-cannabis-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314493\" data-ts=\"1511799840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTU\" target=\"_blank\">INTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314493-intuit-selects-aws-for-machine-learning-and-ai-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuit selects AWS for machine learning and AI platform</a></h4><ul><li>        Intuit (NASDAQ:<a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a>) <a href=\"http://www.businesswire.com/news/home/20171127005245/en/Intuit-Selects-AWS-Machine-Learning-Artificial-Intelligence\" target=\"_blank\">selects</a> Amazon Web Services (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) as its machine learning and AI platform.</li><li>               Intuit will integrate the AWS Lex technology into QuickBooks Assistant and other products.&nbsp;</li><li>                  The Lex service builds conversational interfaces into any app using voice and text.    </li><li>               Intuit shares are&nbsp;<font color='green'>up 0.5%</font>.&nbsp;&nbsp;</li><li>        Amazon shares are&nbsp;<font color='green'>up 1%</font>. &nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314406-amazon-announces-vr-developer-tools-video-provider-services\" target=\"_blank\">Amazon announces VR developer tools, video provider services</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314493\" data-linked=\"Intuit selects AWS for machine learning and AI platform\" data-tweet=\"$INTU $INTU $AMZN - Intuit selects AWS for machine learning and AI platform https://seekingalpha.com/news/3314493-intuit-selects-aws-for-machine-learning-and-ai-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3314493-intuit-selects-aws-for-machine-learning-and-ai-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314490\" data-ts=\"1511799224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUDC\" target=\"_blank\">AUDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314490-audiocodes-extends-share-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AudioCodes extends share repurchase program</a></h4><ul><li>        AudioCodes (NASDAQ:<a href='https://seekingalpha.com/symbol/AUDC' title='AudioCodes Ltd.'>AUDC</a>) <a href=\"https://seekingalpha.com/pr/17010851-audiocodes-receives-approval-extension-share-repurchase-program\" target=\"_blank\">receives</a> court approval to repurchase up to $20M additional ordinary shares through May 27. &nbsp;</li><li>           The funding will come from working capital. </li><li> AudioCodes shares are&nbsp;<font color='green'>up 5.2%</font>.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3314490\" data-linked=\"AudioCodes extends share repurchase program\" data-tweet=\"$AUDC - AudioCodes extends share repurchase program https://seekingalpha.com/news/3314490-audiocodes-extends-share-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3314490-audiocodes-extends-share-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314489\" data-ts=\"1511799185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QDEL\" target=\"_blank\">QDEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314489-quidel-down-14-on-beckman-move-to-sell-bnp-assay-directly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quidel down 14% on Beckman move to sell BNP assay directly</a></h4><ul><li>Quidel (<a href='https://seekingalpha.com/symbol/QDEL' title='Quidel Corporation'>QDEL</a> <font color='red'>-14.4%</font>) slumps on double normal volume as investors head for the exits after Beckman Coulter <a href=\"https://www.beckmancoulter.com/wsrportal/page/newsDetail?id=GLB_BCI_158816&amp;searchCorp=undefined&amp;searchProduct=undefined&amp;fromDateProduct=undefined&amp;toDateProduct=undefined&amp;fromDateCorp=undefined&amp;toDateCorp=undefined&amp;market=undefined&amp;productLine=undefined\" target=\"_blank\">announced </a>that it will seek court action to allow it to directly sale a natriuretic peptide assay that is currently exclusively marketed by Quidel pursuant to an agreement with Alere.</li><li>Beckman wants to offer the test for its Access Family of Immunoassay Systems.</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17010992-quidel-confident-legal-strength-validity-supply-agreement-beckman-coulter-sell-bnp-assay\" target=\"_blank\">statement</a>, Quidel says it is \"confident\" in the legal strength and validity of its supply agreement with Beckman Coulter and plans to \"vigorously defend\" its rights under the agreement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314489\" data-linked=\"Quidel down 14% on Beckman move to sell BNP assay directly\" data-tweet=\"$QDEL - Quidel down 14% on Beckman move to sell BNP assay directly https://seekingalpha.com/news/3314489-quidel-down-14-on-beckman-move-to-sell-bnp-assay-directly?source=tweet\" data-url=\"https://seekingalpha.com/news/3314489-quidel-down-14-on-beckman-move-to-sell-bnp-assay-directly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314488\" data-ts=\"1511798856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314488-skechers-pops-after-strong-black-friday-showing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers pops after strong Black Friday showing</a></h4><ul> <li>Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) is <font color='green'>up 3.88%</font> on solid volume after several investment firms call out strong traffic trends for the retail brand on Black Friday.</li> <li>SunTrust's Pamela Quintiliano had Skechers listed as one of her retail winners for Black Friday.</li> <li>Shares of Skechers hit a 52-week high of $34.94 earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314488\" data-linked=\"Skechers pops after strong Black Friday showing\" data-tweet=\"$SKX - Skechers pops after strong Black Friday showing https://seekingalpha.com/news/3314488-skechers-pops-after-strong-black-friday-showing?source=tweet\" data-url=\"https://seekingalpha.com/news/3314488-skechers-pops-after-strong-black-friday-showing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314482\" data-ts=\"1511798548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHPI\" target=\"_blank\">AHPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314482-allied-healthcare-products-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allied Healthcare Products up 22%</a></h4><ul><li>Thinly traded nano cap Allied Healthcare Products (<a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+22.2%</font>) is up more than a 30x surge in volume in early trading.&nbsp; Shares have jumped&nbsp;<font color='green'>42%</font>&nbsp;in two trading days but news is scarce.</li><li>The company makes medical gas construction equipment, respiratory therapy gear, home healthcare products and emergency medical supplies.</li><li>Last quarter's sales were $7.9M (-6.4%).</li></ul><div class=\"tiny-share-widget\" data-id=\"3314482\" data-linked=\"Allied Healthcare Products up 22%\" data-tweet=\"$AHPI - Allied Healthcare Products up 22% https://seekingalpha.com/news/3314482-allied-healthcare-products-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3314482-allied-healthcare-products-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314486\" data-ts=\"1511798548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEA\" target=\"_blank\">CEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314486-select-global-airline-stocks-fall-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select global airline stocks fall back</a></h4><ul> <li>There's some skittish trading on some global airline stocks today.</li> <li>China Eastern Airlines (<a href='https://seekingalpha.com/symbol/CEA' title='China Eastern Airlines Corporation Limited'>CEA</a> <font color='red'>-4.4%</font>) and China Southern Airlines (<a href='https://seekingalpha.com/symbol/ZNH' title='China Southern Airlines Company Limited'>ZNH</a> <font color='red'>-6.1%</font>) are both sharply lower to start the week.</li> <li>Other global airline stocks trading down on the day are Cathay Pacific ADRs (<a href='https://seekingalpha.com/symbol/CPCAY' title='Cathay Pacific Airways, Ltd. ADR'>OTCPK:CPCAY</a>) <font color='red'>-2.3%</font>, LATAM Airlines LATAM LTM <font color='red'>-1%</font>, Ryanair (NASDAQ:<a href='https://seekingalpha.com/symbol/RYAAY' title='Ryanair Holdings PLC'>RYAAY</a>) <font color='red'>-1.4%</font> and Copa Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CPA' title='Copa Holdings, S.A.'>CPA</a>) <font color='red'>-1.2%</font>.</li> <li>U.S. carriers are faring better. The U.S. Global Jets ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/JETS' title='U.S. Global Jets ETF'>JETS</a>) is <font color='green'>up 0.07%</font> to stay above the $30 mark.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314486\" data-linked=\"Select global airline stocks fall back\" data-tweet=\"$CEA $CEA $ZNH - Select global airline stocks fall back https://seekingalpha.com/news/3314486-select-global-airline-stocks-fall-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3314486-select-global-airline-stocks-fall-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314458\" data-ts=\"1511798499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314458-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/MGCD' title='MGC Diagnostics Corporation'>MGCD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/QDEL' title='Quidel Corporation'>QDEL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314458\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$AHPI $MGCD $CERC - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3314458-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3314458-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314479\" data-ts=\"1511797812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314479-corbus-pharma-awarded-new-u-s-patent-covering-lead-candidate-anabasum-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharma awarded new U.S. patent covering lead candidate anabasum; shares up 2%</a></h4><ul><li>The USPTO <a href=\"https://seekingalpha.com/pr/17010462-corbus-pharmaceuticals-expands-intellectual-property-portfolio-patent-issuance-covering-use\" target=\"_blank\">issues </a>U.S. Patent No. 9,820,964 to Corbus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='green'>+2.1%</font>) covering the use of pharmaceutical compositions comprising anabasum for the treatment of multiple fibrotic diseases, including systemic sclerosis, dermatomyositis and cystic fibrosis. The patent is in effect through 2034.</li><li>Anabasum is an oral synthetic endocannabinoid-mimetic that preferentially binds to the&nbsp;<a href=\"https://en.wikipedia.org/wiki/Cannabinoid_receptor_type_2\" target=\"_blank\">cannabinoid receptor type 2</a>&nbsp;(CB2) expressed on activated immune cells and&nbsp;<a href=\"https://en.wikipedia.org/wiki/Fibroblast\" target=\"_blank\">fibroblasts</a>. Activating CB2 triggers biochemical pathways that halt fibrosis and inflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314479\" data-linked=\"Corbus Pharma awarded new U.S. patent covering lead candidate anabasum; shares up 2%\" data-tweet=\"$CRBP - Corbus Pharma awarded new U.S. patent covering lead candidate anabasum; shares up 2% https://seekingalpha.com/news/3314479-corbus-pharma-awarded-new-u-s-patent-covering-lead-candidate-anabasum-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3314479-corbus-pharma-awarded-new-u-s-patent-covering-lead-candidate-anabasum-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314477\" data-ts=\"1511797107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314477-jaguar-health-closes-sale-of-2m-common-shares-0_25-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Health closes sale of 2M common shares at $0.25; shares down 2%</a></h4><ul><li>Jaguar Health (<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-1.9%</font>) inks an <a href=\"https://seekingalpha.com/pr/17010688-jaguar-health-enters-share-purchase-agreement-2-million-shares-common-stock-purchase\" target=\"_blank\">agreement </a>with L2 Capital, LLC for the direct sale of 2M shares of common stock at $0.25 per share. Net proceeds of ~$490K will support the ongoing commercialization of Mytesi, working capital and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314477\" data-linked=\"Jaguar Health closes sale of 2M common shares at $0.25; shares down 2%\" data-tweet=\"$JAGX - Jaguar Health closes sale of 2M common shares at $0.25; shares down 2% https://seekingalpha.com/news/3314477-jaguar-health-closes-sale-of-2m-common-shares-0_25-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3314477-jaguar-health-closes-sale-of-2m-common-shares-0_25-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314467\" data-ts=\"1511795523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSM\" target=\"_blank\">BSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314467-black-stone-buys-mineral-royalty-interests-from-noble-energy-for-340m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Black Stone buys mineral, royalty interests from Noble Energy for $340M</a></h4><ul>     <li>Black Stone Minerals (<a href='https://seekingalpha.com/symbol/BSM' title='Black Stone Minerals LP'>BSM</a> <font color='green'>+2.9%</font>) <a href=\"http://investor.blackstoneminerals.com/phoenix.zhtml?c=253789&amp;p=irol-newsArticle&amp;ID=2318535\" target=\"_blank\">agrees to acquire</a> a package of mineral and royalty assets from Noble Energy (<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color='red'>-1.8%</font>) for $340M.</li>     <li>BSM says the assets include ~1.1M gross mineral acres, 380K gross acres of non-participating royalty interests and 600K gross acres of overriding royalty interests collectively spread over 20 states, with major concentrations in Texas, Oklahoma and North Dakota.</li>     <li>Assets to be acquired also include positions in the Powder River Basin in Wyoming, the SCOOP play in Oklahoma and the Granite Wash play in Texas.</li>     <li>BSM says the deal increases its exposure in the Permian Basin through the addition of 8.3K net royalty acres in the Midland Basin and 7.2K net royalty acres in the Delaware Basin, and raises its exposure to the Bakken/Three Forks play by 10K-plus net royalty acres.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314467\" data-linked=\"Black Stone buys mineral, royalty interests from Noble Energy for $340M\" data-tweet=\"$BSM $BSM $NBL - Black Stone buys mineral, royalty interests from Noble Energy for $340M https://seekingalpha.com/news/3314467-black-stone-buys-mineral-royalty-interests-from-noble-energy-for-340m?source=tweet\" data-url=\"https://seekingalpha.com/news/3314467-black-stone-buys-mineral-royalty-interests-from-noble-energy-for-340m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314466\" data-ts=\"1511795244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314466-taiwan-semi-orders-equipment-from-applied-materials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taiwan Semi orders equipment from Applied Materials</a></h4><ul><li>           Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) announces purchasing $17.7M in machinery equipment from Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>). </li><li> TSMC shares are&nbsp;<font color='red'>down 3.6%</font>&nbsp;and AMAT shares are&nbsp;<font color='red'>down 1.7%&nbsp;</font>after this morning&rsquo;s Morgan Stanley downgrades. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3314370-morgan-stanley-cuts-view-samsung-electronics\" target=\"_blank\">Morgan Stanley cuts view on Samsung Electronics</a> (Nov. 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314420-morgan-stanley-downgrades-tsmc-chipmakers-fall\" target=\"_blank\">Morgan Stanley downgrades TSMC, chipmakers fall</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314466\" data-linked=\"Taiwan Semi orders equipment from Applied Materials\" data-tweet=\"$TSM $TSM $AMAT - Taiwan Semi orders equipment from Applied Materials https://seekingalpha.com/news/3314466-taiwan-semi-orders-equipment-from-applied-materials?source=tweet\" data-url=\"https://seekingalpha.com/news/3314466-taiwan-semi-orders-equipment-from-applied-materials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314463\" data-ts=\"1511794800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314463-argus-raises-pt-on-deere\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argus raises PT on Deere</a></h4><ul><li>Deere (NYSE:<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a>) is <font color='green'>up almost 1%</font> in early trade after Argus <a href=\"https://twitter.com/RatingsNetwork/status/935137227339915264\" target=\"_blank\">raised</a> its price target on the stock to $165 from $140.</li><li>It follows the Q4 earnings and solid guidance <a href=\"https://seekingalpha.com/news/3314256-deere-upgraded-buy-deutsche-bank-expected-earnings-revisions\" target=\"_blank\">released</a> by the company this past Friday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314463\" data-linked=\"Argus raises PT on Deere\" data-tweet=\"$DE - Argus raises PT on Deere https://seekingalpha.com/news/3314463-argus-raises-pt-on-deere?source=tweet\" data-url=\"https://seekingalpha.com/news/3314463-argus-raises-pt-on-deere\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314460\" data-ts=\"1511794524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314460-3d-systems-announces-new-med-tech-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems announces new med tech partnership</a></h4><ul><li>        3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a>) and the Radiological Society of North America <a href=\"https://www.3dsystems.com/press-releases/3d-systems-extends-leadership-precision-healthcare-technology-advancements-quickly?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+3dSystemsRssNewsFeed+%283D+Systems+RSS+News+Feed%29\" target=\"_blank\">announce</a> a new D2P tech to help clinicians and radiologists create fast but accurate digital 3D anatomical models.</li><li>                  3D will also develop Volume Victual Reality tech allowing physicians to upload patient scan data to D2P to immediately visualize datasets in VR.    </li><li>               3D Systems shares are<font color='green'> up 1.47%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3314460\" data-linked=\"3D Systems announces new med tech partnership\" data-tweet=\"$DDD - 3D Systems announces new med tech partnership https://seekingalpha.com/news/3314460-3d-systems-announces-new-med-tech-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3314460-3d-systems-announces-new-med-tech-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314457\" data-ts=\"1511794076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314457-teva-shakes-up-management-shores-up-operations-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva shakes up management as it shores up operations; shares up 5%</a></h4><ul><li>Teva Pharmaceutical Industries' (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+4.8%</font>) new CEO K&aring;re Schultz takes <a href=\"https://seekingalpha.com/pr/17010720-teva-announces-new-organization-structure-leadership-changes\" target=\"_blank\">decisive action</a> aimed at stabilizing the business. The company has realigned its operations and management aimed at increasing internal efficiencies and improving profitability.</li><li>Commercial operations, historically divided between generic and specialty medicines, will operate as one group across three regions (North America, Europe and Growth Markets). Each will be responsible for their own product portfolios including generics, specialty and over-the-counter.</li><li>Generic R&amp;D and Specialty R&amp;D will combine into one global group.</li><li>A newly formed Market &amp; Portfolio function will oversee the coordination between the regions, R&amp;D and operations throughout all stages of the product lifecycle aimed at optimizing the company's product lineup across all therapeutic areas.</li><li>Management responsibilities:</li><li>Interim CFO Mike McClellan will serve as EVP and permanent CFO.</li><li>Dr. Hafrun Fridriksdottir will serve as EVP, Global R&amp;D. Previously, she was SVP and President of Global Generics R&amp;D at Allergan.</li><li>Brendan O'Grady will serve as EVP, North America Commercial (formerly Chief Commercial Officer, Global Specialty Medicine).</li><li>Richard Daniell will serve as EVP, European Commercial (formerly President &amp; CEO, Teva Generics Europe).</li><li>Gianfranco Nazzi, former President &amp; CEO of Growth Markets Generics, will serve as EVP, Growth Markets Commercial.</li><li>Sven Dethlefs will serve as EVP, Global Marketing &amp; Portfolio (formerly Global Head of Respiratory Medicines).</li><li>Dr. Michael Hayden, Dr. Rob Koremans and Dipankar Bhattacharjee will retire effective year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314457\" data-linked=\"Teva shakes up management as it shores up operations; shares up 5%\" data-tweet=\"$TEVA - Teva shakes up management as it shores up operations; shares up 5% https://seekingalpha.com/news/3314457-teva-shakes-up-management-shores-up-operations-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3314457-teva-shakes-up-management-shores-up-operations-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314452\" data-ts=\"1511793724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUDA\" target=\"_blank\">CUDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314452-barracuda-networksplus-15_7-on-1_6b-go-private-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barracuda Networks +15.7% on $1.6B go-private deal</a></h4><ul>   <li>Barracuda Networks (NYSE:<a href='https://seekingalpha.com/symbol/CUDA' title='Barracuda Networks, Inc'>CUDA</a>) is <font color='green'>up 15.7%</font> out of today's open after announcing it will be <a href=\"https://seekingalpha.com/pr/17010751-barracuda-agrees-acquired-thoma-bravo-1_6-billion\" target=\"_blank\">taken private by Thoma Bravo</a>, for $1.6B.</li>    <li>The deal's all cash, $27.55 for each common share of Barracuda, a 22.5% premium to its 10-day average.</li>    <li>Barracuda's board has unanimously approved. The deal's expected to be done before Barracuda's fiscal year ends on Feb. 28.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314452\" data-linked=\"Barracuda Networks +15.7% on $1.6B go-private deal\" data-tweet=\"$CUDA - Barracuda Networks +15.7% on $1.6B go-private deal https://seekingalpha.com/news/3314452-barracuda-networksplus-15_7-on-1_6b-go-private-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3314452-barracuda-networksplus-15_7-on-1_6b-go-private-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314447\" data-ts=\"1511792952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314447-rokuplus-4-on-price-target-boost-needham\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +4% on price target boost at Needham</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) is <font color='green'>up 4%</font> premarket after getting its price target <a href=\"https://www.streetinsider.com/Analyst+Comments/Roku+Inc.+%28ROKU%29+PT+Raised+to+%2450+at+Needham+%26+Company%3B+Compares+to+Netflix/13540012.html\" target=\"_blank\">raised to a street-high $50</a> from Needham's Laura Martin.</li>    <li>Roku's at $39.47, implying 27% upside.</li>    <li>She's boosting 2018 estimates and expects Roku to hit break-even in EBITDA in Q3 2018, a quarter earlier than expected.</li>    <li>\"Like NFLX, we view ROKU as a pure-play on over-the-top &#40;OTT&#41; TV-viewing growth, but ROKU has no content risk. Recent announcements and press reports that DIS, GOOG, AMZN, etc. are launching new OTT services helps ROKU but hurts NFLX,\" she writes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314447\" data-linked=\"Roku +4% on price target boost at Needham\" data-tweet=\"$ROKU - Roku +4% on price target boost at Needham https://seekingalpha.com/news/3314447-rokuplus-4-on-price-target-boost-needham?source=tweet\" data-url=\"https://seekingalpha.com/news/3314447-rokuplus-4-on-price-target-boost-needham\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314445\" data-ts=\"1511792748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314445-nuance-communications-up-after-rollout-of-radiology-ai-marketplace\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance Communications up after rollout of radiology AI Marketplace</a></h4><ul>   <li>Nuance Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) is <font color='green'>up 6.4%</font> premarket after unveiling the <a href=\"https://seekingalpha.com/pr/17010582-nuance-unveils-world-s-first-open-artificial-intelligence-marketplace-diagnostic-imaging\" target=\"_blank\">Nuance AI Marketplace for Diagnostic Imaging</a>, a platform to advance artificial intelligence in medical images.</li>    <li>The company says 70% of U.S. radiologists already use Nuance's PowerScribe reporting and PowerShare image exchange network, and the new AI Marketplace unlocks the power of artificial intelligence for all radiologists.</li>    <li>The initiative comes with a number of partners, including Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>), with which Nuance has announced a broader collaboration to advance AI in radiology.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314365-ge-nvidia-partner-bringing-ai-platform-ge-healthcare\" target=\"_blank\">GE, Nvidia to partner in bringing AI platform to GE Healthcare</a> (Nov. 26 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314445\" data-linked=\"Nuance Communications up after rollout of radiology AI Marketplace\" data-tweet=\"$NUAN $NUAN $NVDA - Nuance Communications up after rollout of radiology AI Marketplace https://seekingalpha.com/news/3314445-nuance-communications-up-after-rollout-of-radiology-ai-marketplace?source=tweet\" data-url=\"https://seekingalpha.com/news/3314445-nuance-communications-up-after-rollout-of-radiology-ai-marketplace\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314444\" data-ts=\"1511792448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314444-holiday-cheer-for-gun-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Holiday cheer for gun stocks</a></h4><ul> <li>It's not your traditional Black Friday stock play, but shares of American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) are moving higher after reports of a strong level of FBI background checks poured in.</li> <li>Bloomberg reports the number of request topped 200K vs. 186K last year.</li> <li>AOBC <font color='green'>+3.54%</font> premarket to $13.75. Sturm, Ruger (NYSE:<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a>) could also see a bounce when trading starts.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314444\" data-linked=\"Holiday cheer for gun stocks\" data-tweet=\"$AOBC $AOBC $RGR - Holiday cheer for gun stocks https://seekingalpha.com/news/3314444-holiday-cheer-for-gun-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3314444-holiday-cheer-for-gun-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314442\" data-ts=\"1511792424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLIC\" target=\"_blank\">KLIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314442-kulicke-soffa-cfo-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kulicke &amp; Soffa CFO steps down</a></h4><ul><li>        Kulicke &amp; Soffa (NASDAQ:<a href='https://seekingalpha.com/symbol/KLIC' title='Kulicke and Soffa Industries, Inc.'>KLIC</a>) <a href=\"https://seekingalpha.com/pr/17010341-kulicke-and-soffa-industries-inc-announces-appointment-new-cfo\" target=\"_blank\">announces</a> that Jonathan Chou has stepped down as EVP, CFO, and Principal Accounting Officer effective immediately.</li><li>               Chou will remain with the company until February 28 to aid with the transition.&nbsp;</li><li>               Lester Wong, general counsel and SVP of Legal Affairs, will step into the role of interim CFO while the company looks for a permanent replacement. &nbsp;&nbsp;</li><li>Kulicke &amp; Soffa shares are&nbsp;<font color='red'>down 1.7%</font>.&nbsp; &nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3314442\" data-linked=\"Kulicke &amp; Soffa CFO steps down\" data-tweet=\"$KLIC - Kulicke &amp; Soffa CFO steps down https://seekingalpha.com/news/3314442-kulicke-soffa-cfo-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3314442-kulicke-soffa-cfo-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314441\" data-ts=\"1511792264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314441-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a> <font color='green'>+42%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a> <font color='green'>+39%</font>&nbsp;as bitcoin <a href=\"https://seekingalpha.com/news/3314371-bitcoin-shoots-10000\" target=\"_blank\">shoots</a> to $10,000</li>     <li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+15%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17010737-mtbc-announces-signing-largest-client-950-provider-group\" target=\"_blank\">signing</a> of a 950 provider multi-state therapy group.</li>     <li><a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+17%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color='green'>+11%</font>&nbsp;as Firdapse <a href=\"https://seekingalpha.com/news/3314400-catalyst-pharmas-firdapse-successful-second-late-stage-study-lems-shares-3-percent-premarket\" target=\"_blank\">successful</a> in second late-stage study in LEMS.</li>     <li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+12%</font>.</li>     <li>TIME <font color='green'>+9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+9%</font>&nbsp;as&nbsp;&nbsp;subsidiary Aptito, LLC <a href=\"https://seekingalpha.com/pr/17010609-aptito-elo-partner-provide-modern-best-class-point-sale-solution\" target=\"_blank\">partnered</a> with Elo.</li>     <li><a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314441\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SSC-OLD $MARA $MTBC - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3314441-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3314441-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314438\" data-ts=\"1511791995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BV-OLD\" target=\"_blank\">BV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314438-bazaarvoiceplus-13_5-on-acquisition-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bazaarvoice +13.5% on acquisition announcement</a></h4><ul><li>        Bazaarvoice (NASDAQ:<a href='https://seekingalpha.com/symbol/BV-OLD' title='Bazaarvoice'>BV-OLD</a>) <a href=\"https://seekingalpha.com/pr/17010630-bazaarvoice-inc-enters-definitive-agreement-acquired-marlin-equity-partners\" target=\"_blank\">enters</a> into a definitive agreement to be acquired by Marlin Equity <br> Partners.</li><li>               Marlin will acquire every share of outstanding common stock for $5.50 in cash for a total of around $521M. &nbsp;&nbsp;</li><li>               After the transaction completes, Bazaarvoice will become a privately held company.&nbsp;</li><li>               Bazaarvoice shares are&nbsp;<font color='green'>up 13.5%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314428-bazaarvoice-reports-q2-results\" target=\"_blank\">Bazaarvoice reports Q2 results</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314438\" data-linked=\"Bazaarvoice +13.5% on acquisition announcement\" data-tweet=\"$BV-OLD - Bazaarvoice +13.5% on acquisition announcement https://seekingalpha.com/news/3314438-bazaarvoiceplus-13_5-on-acquisition-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3314438-bazaarvoiceplus-13_5-on-acquisition-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314436\" data-ts=\"1511791689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314436-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>&nbsp;<font color='red'>-10%</font>&nbsp;on Bitcoin <a href=\"https://seekingalpha.com/news/3314371-bitcoin-shoots-10000\" target=\"_blank\">boom</a>.</li><li><a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3314436\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$RIOT $DCIX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3314436-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3314436-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314435\" data-ts=\"1511791604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNTC\" target=\"_blank\">BNTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314435-benitec-advancing-gene-therapy-candidate-bbminus-301-shares-ahead-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benitec advancing gene therapy candidate BB-301; shares ahead 15% premarket</a></h4><ul><li>Thinly traded nano cap Benitec Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a>) is up&nbsp;<font color='green'>15%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17010548-benitec-biopharma-provides-update-opmd-orphan-disease-program\" target=\"_blank\">announcement </a>that it is on track for an IND filing in Q4 2018 in the U.S. for gene therapy BB-301 for the treatment of oculopharyngeal muscular dystrophy &#40;OPMD&#41;. An initial study in humans should commence shortly thereafter.</li><li>BB-301 is a single-vector (gene therapy construct) system that uses DNA-directed RNA interference to silence the expression of the mutant gene associated with OPMD while adding back a normal copy of the gene to restore function.</li><li>The company has filed an application with the FDA seeking Orphan Drug status for the indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314435\" data-linked=\"Benitec advancing gene therapy candidate BB-301; shares ahead 15% premarket\" data-tweet=\"$BNTC - Benitec advancing gene therapy candidate BB-301; shares ahead 15% premarket https://seekingalpha.com/news/3314435-benitec-advancing-gene-therapy-candidate-bbminus-301-shares-ahead-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3314435-benitec-advancing-gene-therapy-candidate-bbminus-301-shares-ahead-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314432\" data-ts=\"1511791254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314432-ubs-lowers-iphone-sales-fy18-eps-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS lowers iPhone sales, FY18 EPS estimates</a></h4><ul><li>           UBS <a href=\"https://www.cnbc.com/2017/11/27/ubs-lowers-iphone-sales-forecast-as-survey-shows-more-muted-demand.html\" target=\"_blank\">lowers</a> its 2018 Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone unit sales growth forecast from 12% to 10% following a customer survey. </li><li> Analyst Steven Milunovich writes that a survey of 6.7K smartphone buyers in five countries showed &ldquo;flattish&rdquo; buying intentions from last year, which hints at a &ldquo;more muted&rdquo; unit growth than expected. </li><li> The analyst notes that &ldquo;F18 unit growth might not be explosive, but a rising ASP helps.&rdquo; </li><li> Milunovich also lowers Apple&rsquo;s FY18 EPS estimate from $11.65 to $11.50. </li><li> UBS reaffirms its Buy rating and $190 price target on Apple. </li><li> Apple shares are&nbsp;<font color='red'>down 0.13%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3314092-apple-release-lower-cost-iphone-se-2-1h18\" target=\"_blank\">Apple could release lower cost iPhone SE 2 in 1H18</a> (Nov. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314432\" data-linked=\"UBS lowers iPhone sales, FY18 EPS estimates\" data-tweet=\"$AAPL - UBS lowers iPhone sales, FY18 EPS estimates https://seekingalpha.com/news/3314432-ubs-lowers-iphone-sales-fy18-eps-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3314432-ubs-lowers-iphone-sales-fy18-eps-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314430\" data-ts=\"1511790855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314430-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Allergan (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) resumed with Outperform rating and $237 (37% upside) price target by Leerink.</li><li>Allena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNA' title='Allena Pharmaceuticals, Inc.'>ALNA</a>) initiated with Buy rating and $22 (69% upside) by Jefferies. Initiated with Outperform rating by Cowen and Credit Suisse. Initiated with Outperform rating and $30 (131% upside) by Wedbush.</li><li>CareDx (NASDAQ:<a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a>) initiated with Buy rating and $12 (79% upside) by H.C. Wainwright.</li><li>Ironwood Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IRWD' title='Ironwood Pharmaceuticals, Inc.'>IRWD</a>) initiated with Outperform rating and $19 (21% upside) by Credit Suisse.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) initiated with Overweight rating and $31 (17% upside) by Barclays.</li><li>Spero Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a>) initiated with Buy rating and $26 (88% upside) price target by Stifel. Initiated with Outperform rating by Cowen. Initiated with Neutral rating and $16 price target by BofAML. Initiated with Outperform rating and $30 price target by Oppenheimer.</li><li>Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) initiated with Outperform rating and $56 (44% upside) price target by JMP Securities.</li><li>ChromaDex (NASDAQ:<a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a>) initiated with Buy rating and $8 (19% upside) price target by H.C. Wainwright.</li><li>Arrowhead Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a>) upgraded to Overweight by Piper Jaffray.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314430\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$AGN $AGN $ALNA - Premarket analyst action - healthcare https://seekingalpha.com/news/3314430-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3314430-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314427\" data-ts=\"1511790424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314427-gap-shoots-to-52-week-high-off-black-friday-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap shoots to 52-week high off Black Friday buzz</a></h4><ul> <li>Shares of Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>) are higher in early action on more reports that the mall stalwart topped some beaten-down expectations for traffic over the Black Friday weekend.</li> <li>Though no official sales numbers have been reported, retail channel checks indicate long lines at Gap stores throughout the weekend and a higher level of consumer interest online.</li><li>Sources: TheStreet, Retail Dive, Bloomberg</li> <li>GPS <font color='green'>+2.97%</font> premarket to a 52-week high of $30.52.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314427\" data-linked=\"Gap shoots to 52-week high off Black Friday buzz\" data-tweet=\"$GPS - Gap shoots to 52-week high off Black Friday buzz https://seekingalpha.com/news/3314427-gap-shoots-to-52-week-high-off-black-friday-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3314427-gap-shoots-to-52-week-high-off-black-friday-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314424\" data-ts=\"1511789889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314424-protalix-bios-fabry-candidate-prxminus-102-shows-positive-effect-in-phase-1-2-extension-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix Bio&#39;s Fabry candidate PRX-102 shows positive effect in Phase 1/2 extension study; shares ahead 6% premarket</a></h4><ul><li>Protalix BioTherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17010434-protalix-biotherapeutics-presents-positive-results-phase-ii-open-label-extension-trial\" target=\"_blank\">announcement </a>of positive results from a Phase 1/2 open-label extension study assessing PRX-102 in patients with Fabry Disease. The data were presented at the New Horizons in Fabry Disease Conference in Dallas, TX.</li><li>Results at month 24 showed sustained responses across all key Fabry parameters, including a 90% decrease from baseline in Lyso Gb3 levels, stable renal and cardiac function and a 40% improvement in disease severity.</li><li>19% (n=3/16) of patients formed antidrug antibodies (two with neutralizing antibodies) in the first 12 months of treatment, but all turned negative over the following 12 months of treatment.</li><li><a href=\"http://www.protalix.com/development-pipeline/prx-102-fabry-disease.asp\" target=\"_blank\">PRX-102</a>&nbsp;is chemically modified version of a recombinant therapeutic enzyme called alpha-galactosidase A. It is currently being evaluated in three Phase 3 studies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314424\" data-linked=\"Protalix Bio&#39;s Fabry candidate PRX-102 shows positive effect in Phase 1/2 extension study; shares ahead 6% premarket\" data-tweet=\"$PLX - Protalix Bio&#39;s Fabry candidate PRX-102 shows positive effect in Phase 1/2 extension study; shares ahead 6% premarket https://seekingalpha.com/news/3314424-protalix-bios-fabry-candidate-prxminus-102-shows-positive-effect-in-phase-1-2-extension-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3314424-protalix-bios-fabry-candidate-prxminus-102-shows-positive-effect-in-phase-1-2-extension-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314420\" data-ts=\"1511789469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314420-morgan-stanley-downgrades-tsmc-chipmakers-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley downgrades TSMC, chipmakers fall</a></h4><ul><li>        Chipmakers move after Morgan Stanley&rsquo;s downgrade of Samsung and Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) from Overweight to Equal Weight.</li><li>               The firm commented on NAND prices dropping in Q4 and uncertain DRAM dynamics beyond 1Q18 and related shares are dropping.&nbsp;</li><li>               TSM shares are&nbsp;<font color='red'>down 2.3%</font>.&nbsp;</li><li>               Other chipmaker movers: Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) is&nbsp;<font color='red'>down 3.7%</font>, Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) is&nbsp;<font color='red'>down 2.6%</font>, Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) is&nbsp;<font color='red'>down 1.2%</font>; Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) is&nbsp;<font color='red'>down 1.6%</font>.&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314370-morgan-stanley-cuts-view-samsung-electronics\" target=\"_blank\">Morgan Stanley cuts view on Samsung Electronics</a> (Nov. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314420\" data-linked=\"Morgan Stanley downgrades TSMC, chipmakers fall\" data-tweet=\"$TSM $TSM $WDC - Morgan Stanley downgrades TSMC, chipmakers fall https://seekingalpha.com/news/3314420-morgan-stanley-downgrades-tsmc-chipmakers-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3314420-morgan-stanley-downgrades-tsmc-chipmakers-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314410\" data-ts=\"1511788013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314410-clean-energy-landi-renzo-to-combine-compressor-businesses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy, Landi Renzo to combine compressor businesses</a></h4><ul>     <li>Clean Energy Fuels (NASDAQ:<a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a>)&nbsp;<font color='green'>+3.2%</font> premarket on news it is <a href=\"https://seekingalpha.com/pr/17010350-landi-renzo-clean-energy-combine-compressor-businesses-setting-new-global-powerhouse\" target=\"_blank\">combining</a> its compressor manufacturing subsidiary with Italian firm Landi Renzo's similar unit to form a new standalone company.</li>     <li>The companies say CLNE, established in North and South America, and Landi Renzo's SAFE, with a strong presence in Europe and Asia, will become one of the world's       leading suppliers of natural gas compressors and related products.</li><li>Landi       Renzo will own 51% of the new company and take over operational       management, while CLNE will retain a 49% stake, and CLNE&nbsp;President and CEO Andrew Littlefair will become       chairman.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3314410\" data-linked=\"Clean Energy, Landi Renzo to combine compressor businesses\" data-tweet=\"$CLNE - Clean Energy, Landi Renzo to combine compressor businesses https://seekingalpha.com/news/3314410-clean-energy-landi-renzo-to-combine-compressor-businesses?source=tweet\" data-url=\"https://seekingalpha.com/news/3314410-clean-energy-landi-renzo-to-combine-compressor-businesses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314407\" data-ts=\"1511787582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314407-biogen-teams-up-alkermes-to-develop-ms-candidate-alks-8700\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen teams up with Alkermes to develop MS candidate ALKS 8700</a></h4><ul><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) and Alkermes plc (NASDAQ:<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>) enter into a global license and collaboration <a href=\"https://seekingalpha.com/pr/17010427-biogen-alkermes-announce-license-collaboration-agreement-develop-commercialize-alks-8700\" target=\"_blank\">agreement </a>to develop and commercialize ALKS 8700 for the treatment of relapsing forms of multiple sclerosis &#40;MS&#41;.</li><li>Under the terms of the agreement, Alkermes will receive $28M upfront, milestones up to $200M and mid-teens royalties on global net sales. Biogen secures an exclusive worldwide license to commercialize ALKS 8700 and will be responsible for all development expenses as of January 1, 2018. The $28M payment represents Biogen's share of development expenses incurred this year.</li><li>Alkermes will be responsible for submitting the marketing application in the U.S. It plans to seek approval under the abbreviated 505(b)(2) pathway referencing Biogen's TECFIDERA (dimethyl fumarate) as the reference drug.</li><li>Phase 3-stage ALKS 8700 is a monomethyl fumarate prodrug designed to be easier on the GI tract than TECFIDERA.</li><li>ALKS is up&nbsp;<font color='green'>2%</font>&nbsp;premarket and BIIB is up&nbsp;<font color='green'>1%</font>, both on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2871606-alkermes-confident-can-file-nda-2018-alks-8700\" target=\"_blank\">Alkermes confident it can file an NDA in 2018 for ALKS 8700</a> (Oct. 29, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3314407\" data-linked=\"Biogen teams up with Alkermes to develop MS candidate ALKS 8700\" data-tweet=\"$BIIB $BIIB $ALKS - Biogen teams up with Alkermes to develop MS candidate ALKS 8700 https://seekingalpha.com/news/3314407-biogen-teams-up-alkermes-to-develop-ms-candidate-alks-8700?source=tweet\" data-url=\"https://seekingalpha.com/news/3314407-biogen-teams-up-alkermes-to-develop-ms-candidate-alks-8700\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3314400\" data-ts=\"1511785828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3314400-catalyst-pharmas-firdapse-successful-in-second-late-stage-study-in-lems-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma&#39;s Firdapse successful in second late-stage study in LEMS; shares up 3% premarket</a></h4><ul><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) is up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17010383-catalyst-pharmaceuticals-announces-positive-top-line-results-second-phase-3-clinical-trial\" target=\"_blank\">announcement </a>that a second Phase 3 study, LMS-003, assessing Breakthrough Therapy-tagged Firdapse (amifampridine phosphate tablets) for the symptomatic treatment of Lambert-Eaton myasthenic syndrome &#40;LEMS&#41; met its two co-primary endpoints.</li><li>LEMS is an autoimmune disorder characterized by muscle weakness in the arms and legs caused by the buildup of antibodies at the connection between nerve and muscle (neuromuscular junction). It commonly strikes people over the age of 40 and is prevalent in those with lung cancer.</li><li>The results will be submitted for presentation at future medical conferences and for publication.</li><li>The company expects to file a U.S. marketing application next quarter.</li><li>Management will host a conference call this morning at 8:30 am ET to discuss the results.</li><li>The company conducted the second study at the request the FDA.</li><li><a href=\"http://catalystpharma.com/pdf/CPP14005_ANAPoster_RD19M.pdf\" target=\"_blank\">Amifampridine</a>&nbsp;enhances neuromuscular transmission by blocking the potassium channel. This causes depolarization of the presynaptic membranes which opens the calcium channel thereby enabling muscle fibers to contract.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3175784-catalyst-pharma-48-percent-fda-says-new-phase-3-study-needed-firdapse-nda\" target=\"_blank\">Catalyst Pharma down 48% after FDA says new Phase 3 study needed for Firdapse NDA</a> (April 26, 2016)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3114086-fda-rejects-catalyst-pharmas-firdapse-nda-shares-slump-38-percent\" target=\"_blank\">FDA rejects Catalyst Pharma's Firdapse NDA; shares slump 38%</a> (Feb. 17, 2016)</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3314400\" data-linked=\"Catalyst Pharma&#39;s Firdapse successful in second late-stage study in LEMS; shares up 3% premarket\" data-tweet=\"$CPRX - Catalyst Pharma&#39;s Firdapse successful in second late-stage study in LEMS; shares up 3% premarket https://seekingalpha.com/news/3314400-catalyst-pharmas-firdapse-successful-in-second-late-stage-study-in-lems-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3314400-catalyst-pharmas-firdapse-successful-in-second-late-stage-study-in-lems-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}